An insurtech conversion experiment can change more than a button or headline. It may alter how a prospect describes a risk, what information is requested, how a product is understood, or whether a broker trusts the next step. A higher click-through rate is not enough to approve a change that creates a misleading promise or weakens consent.
This audit checklist gives marketing, product, compliance, analytics, and sales a shared way to inspect experiments before and after launch.
1. Define the decision and audience
Write the page, journey, audience, market, traffic source, and decision the experiment supports. Specify whether the intended outcome is a consultation, quote request, demo, broker conversation, or educational step.
Record exclusions for regulated products, vulnerable audiences, jurisdictions, and existing customers. An experiment that is safe for one path may not be safe for another.
2. Test the hypothesis
State the observed problem, proposed change, expected mechanism, primary outcome, guardrail, and decision rule. “Make the page more compelling” is not a testable hypothesis. “Clarifying the implementation boundary may increase qualified consultation requests without increasing unsuitable inquiries” is closer.
Name the evidence that supports the mechanism and the uncertainty that remains. Keep interpretation separate from observation.
3. Review claims and disclosures
Inventory every changed claim, proof point, testimonial, comparison, fee reference, eligibility statement, and risk explanation. Identify the approver and the source. Do not let a design variant bypass legal, compliance, or customer-privacy review.
Use plain language and show relevant conditions near the decision. Google’s people-first guidance is useful as a quality check, but it does not replace an insurtech-specific approval.
4. Check consent and data minimisation
Audit form fields, cookies, contact preferences, enrichment, recording, and storage. Ask whether every field is necessary for the stated next step and whether the visitor can understand the choice.
Do not request policy, claim, health, financial, or security details in a general experiment form. Provide a controlled route for sensitive discussion and record the boundary in the brief.
5. Confirm measurement integrity
Define exposure, eligibility, primary event, secondary events, exclusions, attribution window, and sample-quality rule. Google Ads experiment guidance can be a platform reference; local measurement definitions must still be documented.
Use Google Analytics key events as event signals, then reconcile lead suitability, broker context, qualification, and downstream outcome. A click is not a policy decision.
6. Set safety guardrails
Choose guardrails for unsuitable submissions, complaint rate, incomplete disclosure, abandonment at a sensitive question, support load, and data-quality errors. Set a stop condition before launch and give one person authority to pause.
Test the fallback experience. If the experiment is disabled, the visitor should still receive an accurate explanation and a safe next step.
7. Govern execution and access
Record platform, version, traffic allocation, start and end criteria, implementation owner, QA reviewer, and rollback method. Limit access to the minimum needed and keep a change log.
Run an independent preflight on mobile, form submission, confirmation, analytics, consent, accessibility, and the original control. A green deployment status is not evidence that the customer journey is correct.
8. Interpret results carefully
Review primary outcome, guardrails, segment differences, sample quality, business stage, and confidence. Do not generalise from a narrow audience or a short period affected by a launch, broker event, or outage.
Record inconclusive results without forcing a winner. Learning that a mechanism did not hold is a valid outcome when the next decision is explicit.
9. Use the audit checklist
| Audit area | Evidence | Pass condition | | — | — | — | | scope | audience, page, decision | boundaries are explicit | | hypothesis | problem, mechanism, outcome | falsifiable statement | | claims | source, condition, approver | accurate and permitted | | consent | fields, notice, storage | minimum necessary data | | measurement | exposure, event, denominator | reproducible definition | | safety | guardrail, stop owner, fallback | reversible execution | | delivery | version, QA, access, rollback | independently checked | | interpretation | segments, quality, uncertainty | no overclaiming |
Add an evidence note to the final decision. State which segments were included, which were excluded, whether the guardrails moved, and what the experiment did not test. If the outcome is positive, describe the condition under which it appeared; if it is negative or inconclusive, preserve the mechanism that was challenged. The note should be readable by compliance, product, analytics, and the next experiment owner. It is the bridge between a local page change and a responsible learning system.
Keep the control version available until the review is closed. A later product, traffic, or consent change can make a previously observed lift disappear, and the original comparison is needed to diagnose that break. If a variant is rolled out, state the rollout population and the new guardrail owner. If it is retired, record why and preserve the learning. This discipline prevents a winning screenshot from becoming an unqualified permanent claim.
Repeat the audit when a product, jurisdiction, partner route, or form changes. An experiment is governed when the team can explain what it learned, what it protected, and why the next version is safe enough to test.
Keep the control experience and the decision record available after the experiment ends. If a later complaint or data-quality issue appears, the team should be able to reconstruct who saw the change, which disclosure was approved, what guardrail was monitored and who authorized rollout. Retention should follow the company’s privacy and compliance policy.
Review inconclusive tests as carefully as winning ones. A result may be inconclusive because the hypothesis was weak, the audience was mixed, the sample window was short or the event join failed. The right follow-up can be better research, a narrower audience, a measurement repair or a decision to stop learning on that path.
Make the release decision explicit: keep the control, revise the treatment, extend the test, or retire the hypothesis. Record the reason and the person who accepted the residual risk. That small discipline keeps experimentation connected to accountability.
How did this article land?
Choose one reaction. You can change it anytime.
